Established in 1998 in Shenzhen, China, Hepalink is a leading multinational biopharmaceutical company dual-listed in Hong Kong and mainland China. Driven by patient’s unmet needs, Hepalink is striving to fulfill its mission of bringing safe and effective therapies and services to patients around the world.
1998
years
Established in 1998 in Shenzhen
a+h
stocks
Dual-listed in Hong Kong and mainland China
50+
countries and regions
With presence and business operations in over 40 countries and regions around the world
Covering heparin industrial chain, CDMO services of large molecule biologic products, and the research, development, and commercialization of innovative drugs.
